University of Pennsylvania · 4 months ago
Cell Processing Technologist (CVPF)
Smilow Center for Translational
Full-time
Hybrid
New Grad, Entry Level
$40K/yr - $55K/yr
0+ years expThe University of Pennsylvania is a prestigious institution known for its leadership in education and research. The Cell Processing Technologist will be responsible for conducting day-to-day activities related to cell and gene therapy clinical trials, including operating bioprocessing equipment and maintaining clinical cell cultures.
Continuing EducationEdTechEducationSTEM EducationUniversities
Responsibilities
Aseptic cell processing following established Standard Operating Procedures. Accurate documentation following Good Documentation Practices. Prepare cell processing materials, media, and raw materials required to perform cellular manufacturing processes
Perform required daily maintenance of clinical cell cultures. Perform cryopreservation of cell therapy products using a controlled-rate freezer
Proficient operation of cell processing equipment, which may include automated cell washer, controlled rate freezer, biological safety cabinets, culture incubators, liquid nitrogen freezers, tubing welders and sealers and others as assigned
Compliance with departmental policies and procedures. Accurate documentation of deviations and unexpected events
Remain current on required trainings
Other duties and responsibilities as assigned
Qualification
Required
Bachelor of Science and 0 to 1 year of experience or equivalent combination of education and experience is required
Benefits
Health, Life, and Flexible Spending Accounts
Tuition
Retirement
Time Away from Work
Long-Term Care Insurance
Wellness and Work-life Resources
Professional and Personal Development
University Resources
Discounts and Special Services
Flexible Work Hours
Penn Home Ownership Services
Adoption Assistance
Company
University of Pennsylvania
The University of Pennsylvania is an American private Ivy League Research University that excels in producing future leaders.
10001+ employees
Funding
Current Stage
Late StageTotal Funding
$81.46MKey Investors
National Science FoundationUS Department of EnergyParent Project Muscular Dystrophy
2024-08-28Grant
2023-06-26Grant· $18M
2022-09-15Grant· $55M
Leadership Team
Mark Dingfield
Executive Vice President
Angela Duckworth
Faculty Co-Director of Wharton People Analytics
Recent News
2026-01-16
The Philadelphia Inquirer
2026-01-16
Company data provided by crunchbase